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Abstract This work aims to assess the impact of 
maintenance-oriented design on a production line in the 
pharmaceutical industry, which includes operations in a 
clean room. 
The case study analyses the downtimes of a production 
line of large volume parental solutions. 
The results obtained at the end of an appropriate period 
of observation were used to identify the main problems, 
in terms of maintenance time. 
Some of the critical issues were overcome by requiring 
that part of the production line be redesigned by a 
company specialized in the design of clean room lines. 
In this context, the focus of the case study is not on the 
technical aspects of maintenance-oriented design 
application, but its consequences in terms of the increase 
in performance. 
The performance of the new production line was 
analysed and compared with that obtained in the first 
phase of the study. This comparison allowed us to 
estimate and quantify the achieved improvements 
referring to system availability and consequently to a 
production increase quantified at more than 110,000 units 
per year. 
The impact of the maintenance-oriented design was also 
evaluated from an economic point of view. In particular, 
the production increase obtained and the corresponding 
economic advantages were evaluated.  
Through this comparison, it was possible to estimate the 
payback period for the investment of redesign, quantified 
in less than six years. 
 
Keywords Pharmaceutical, Redesign, Availability, 
Reengineering, TPM 
                                         
1. Introduction 
 
Organizations are continuously seeking strategies to improve 
their operations and gain a competitive advantage. 
Maintenance tends to be a key management issue for many 
industrial companies. 
 
Maintenance management, being an integral part of 
manufacturing, can influence competitive companies’ 
priorities, such as cost, quality and flexibility, and, hence, 
business strategy directly [1].  
 
For the pharmaceutical industry it is dramatically 
important to identify strategies to deal with this period 
of stagnation. This is the only way to start to grow up in 
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a world scene that will register a slowdown in the 
coming years, if not a decline in the European market. 
The objectives to be pursued are mainly related to the 
optimization of the production activities of a technical 
or managerial nature. The competitiveness is regained 
by implementing the dictates of their "quality 
management" for continuous improvements in all areas 
of pharmaceutical industry [2-3]. All this can involve 
the optimization of maintenance processes directly 
linked to productive results in terms of defects and 
decreased performance. The present work contains a 
detailed analysis of the pharmaceutical world, in terms 
of maintenance policies, and examines the best practices 
currently in use.  
 
The use of a well applied system of maintenance and 
design maintenance oriented systems, allows to decrease 
downtime and production losses, reducing costs [4]. All 
this also improves the efficiency of the maintenance 
teams, allowing to follow the programming already 
carried out for preventive maintenance. By increasing 
reliability data, some interesting results are also obtained 
such as the cost management.  These aspects can be 
summarized with a saving of 4-7% of the sales costs and 
as much as 20% to over 50% of the costs of the labour 
force [5]. The use of complex equipment and machineries 
has introduced new methods of maintenance, to enable a 
proper use of resources, seeking to limit as much as 
possible the costs due to the stops of the maintained 
machinery [6].  
 
As noted in [7], the success of manufacturing companies 
heavily depends on production performances, in terms of 
increased availability. All this is feasible by optimizing 
and improving maintenance processes. 
 
Total productive maintenance (TPM) is a new concept 
evolving to meet this tremendous requirement of the 
modern competitive industry [8]. TPM is a 
manufacturing programme to maximize the 
effectiveness of equipment throughout its entire life by 
increasing the participation and motivation of the entire 
workforce.  
 
This goal can be achieved through the implementation of 
activities planned to increase equipment efficiency, the 
creation of a programme of autonomous maintenance, the 
establishing of a planned maintenance system, the 
organization of training courses for workers and the 
design of a plant management system.  
 
This situation has led to the need for a rigorously defined 
performance measurement system that is able to take into 
account different important elements of productivity in a 
manufacturing process. 
 
The critical factors which affect the overall equipment 
efficiency (OEE) of the pharmaceutical industry are 
loading time, down time, standard cycle time, actual 
cycle time, units produced and defective units [9]. 
Overall equipment efficiency (OEE) is an indication of 
eight major equipment related losses, which are 
equipment failure, set-up and adjustment, cutting blade 
change, start-up, minor stoppage and idling, speed, 
defects and reworks, and equipment shutdown [10].  
 
According to [11], production scheduling and preventive 
maintenance planning are among the most important 
problems in the manufacturing industry. 
 
Production scheduling aims to respond rapidly to the 
market and to meet customer requirements, by effectively 
assigning jobs or operations to the production system. At 
the same time, preventive maintenance planning is 
carried out to maintain the manufacturing system or to 
restore it to an acceptable operating condition. 
 
In the pharmaceutical industry, the equipment is more 
complex and therefore more difficult to clean, maintain, 
and operate. Poor cleaning procedures can result in the 
cross contamination of batches. Products can also be 
contaminated by worn or poorly maintained equipment. 
The Food and Drug Administration’s (FDA) citations for 
manufacturing deficiencies have even caused delays in 
the FDA approval of new drugs. 
 
Inspectors often find it difficult to determine if good 
engineering practices are used [12]. 
 
Maintenance can impact both the quality of products and 
the compliance of pharmaceutical processes. Maintenance 
programmes have long been recognized as critical to the 
success of the operations they support. In recent years, 
there has been an escalation of requirements imposed on 
maintenance operations, in many cases resulting in added 
cost, slower execution and little or no added value [13]. 
 
The fulfilment of the objectives of maintainability is highly 
dependent on the proper mix of resources and the 
development of good communication [14]. The uniqueness 
of tasks and the many different interfaces that exist, require 
not only good communication skills, but an understanding 
of the system as an entity and of the many design disciplines 
that contribute to its development. Maintainability is only 
one of these design disciplines. However, the successful 
implementation of a maintainability programme’s functions 
requires a thorough understanding not only of system-level 
requirements, but also of the many organizational interfaces 
that exist. 
 
Based on the above statements, it is clear that the 
pharmaceutical industry, as it is highly regulated and 
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faces unique challenges in quality assurance, must also 
ensure that it keeps its equipment maintained and its 
costs down. This forces organizations to review their 
existing practices, which introduces the main research 
question of this study. 
 
2. LVPs production line 
 
The study was performed on a production line for large 
volume parenteral solutions (LVPs), containing 
paracetamol and used particularly in hospital settings. 
 
Large volume parenteral solutions are typically bags or 
bottles, holding 100 ml or more, containing intravenous 
solutions. Common uses of LVP solutions without 
additives include: 
• correction of electrolyte and fluid balance 
disturbances; 
• nutrition; 
• vehicle for administering other drugs. 
 
The production cycle of these solutions presents several 
technical and economical criticalities. 
 
Their production is characterized by low values of gross 
margin contribution (GMC) and is therefore sustainable 
only if done in large quantities. 
 
Some steps of the process must also be done in a clean 
room. This condition greatly complicates many of the 
activities regularly carried out on the line. In particular, all 
the maintenance operations on the parts in contact with the 
product must end with a sterilization step, before 
production can start again. 
 
The phases of the production cycle under study are shown 
in figure 1. 
 
The first step of production involves the cutting and 
weighing of chemical components. This activity takes place 
in designated areas, called "pharmacy". 
 
The active substances and chemicals are divided, according 
to the right proportions, then diluted in distilled water [15] 
and routed to the clean room where bottling is done. 
 
While the chemical dissolution of the drug is performed, 
the bottles, before being filled, are placed in an autoclave, 
in order to be washed and sterilized. 
 
Even the caps and ferrules needed to cork bottles are 
sterilized before being applied. 
 
Once the solution is ready and when the bottles, the caps 
and the ferrules are sterilized, the bottling phase, the most 
critical phase of the process, can start. 
This operation is particularly critical, since it is the only 
time when the drug is in direct contact with the external 
environment, with a risk of contamination [16]. 
 
Once the cap on the bottle has been applied, the next step 
involves the removal of excess air from the bottles through 
a degassing process, by replacing the air with nitrogen. 
 
In order to avoid contamination, the bottling and the 
application of caps are performed in the clean room. 
 
The next step is the assembly of the ferrules and the 
handling of the bottles in a machine that picks them up in 
baskets, placed in a second autoclave for sterilization. 
 
The autoclave can hold four baskets containing 3,600 
bottles each.  
 
The operators working on the ferruling machine also 
perform a regular sampling of the products. 
 
After sterilization, the bottles are removed from the baskets 
and packaged. 
 
The line works 16 hours a day, five days a week and has a 
theoretical capacity of 40 units per minute. Its efficiency is 
approximately 92%, mainly because of production rejects. 
 
The gross margin contribution (GMC) per unit for this 
product is 0,47 €/u. 
 
The analysis focused on the bottling machine. This choice 
was a result of a specific request by the company, since this 
phase is the most critical one. 
 
3. Collecting and analysing data on the bottling machine 
 
A period of observation of the operation of the bottling 
machine of 150 days allowed us to identify the cases of 
machine downtime and the associate abbreviations, 
already used in the company, as shown in table 1 [17]. 
 
The first reason for machine stop is essentially due to a 
bottle being in the wrong position on the handling 
system, or to a bottle being wedged within the cochlea or 
to a breakage. The stops to solve these problems are short 
in time, usually between one and five minutes, and will 
be called micro-stops. The task of resolving these is 
assigned to the operators on the machine.  
 
The production is also interrupted to allow periodic 
cleanings which occur weekly and for the batch change. 
These operations are required by national and 
international standards concerning the production of 
drugs in clean rooms. The cleaning times are scheduled 
exactly [18-19]. 
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Figure 1. Flowchart of the production line 
 
Type of Downtime Abbreviation
Weekly cleaning F.R. 
Batch change cleaning C.L. 
Maintenance cleaning P.M. 
Setup Setup 
Filling failure RP 
Degasing failure GF 
Bottle breaking R.F. 
Bottle lack M.F. 
Solution Lack M.P. 
Wedged coclea C.F.I 
Bottling pump failure P.R. 
Ather stop  Stop 
Table 1. Downtime cases 
 
Added to this, there are the time based and the breakdown 
maintenance operations on the machine due to routine 
activities or to the resolution of accidental failures. 
If, during these activities, the operators have to access the 
clean room, the machine should be sterilized before 
restarting production. These operations will be called 
macro-stops. 
 
The rates of the downtime of the bottling device, grouped 
in the main categories, are shown in Table 2.  
 
For a working time of 135,000 minutes, during the period 
of observation, it is possible to estimate an availability A(t) 
= 93,05% [20,-21]. Referring only to macro-stops, the total 
downtime is 5,008 minutes, corresponding to an 
unavailability U (t) = 3,71%. 
 
Types of downtime  Time (min)
Micro-stops 596 
Weekly cleaning 3,420 
Cleaning for batch change 360 
Macro-stops (with sterilization) 3,966 
Macro-stops (without sterilization) 1,042 
Tot 9,384
Table 2. Rates of the downtime of the bottling device  
 
Relying on a theoretical output of 40 vials per minute, the 
macro-stops’ downtime correspond to a loss of production 
during the observation period equal to 200,320 units. 
 
Standardizing this value to one year of working (234,900 
minutes), it is possible to estimate a theoretical loss of 
production of more than 348,550 units per year. 
 
A detailed analysis of the macro-stops that need 
sterilization before the system is able to restart, shows that 
39% of total unavailability (3.966 minutes) is due to the 
sterilization operations, corresponding to 1,560 minutes.  
 
4. Maintenance-oriented design: strategy and discussion 
 
Based on the presented data, the company implemented a 
redesign of the bottling machines, in order to obtain the 
best performance in terms of productive capacity. 
 
The chosen approach consists of an M-OD, able to predict 
during the design phase possible future maintenance 
activities and to choose all possible precautions, in order to 
improve the system’s reliability and to minimize downtime 
due to maintenance operations. 
 
Such techniques, which are widely used in the 
pharmaceutical field and in clean rooms, are usually 
applied in order to design new production lines. 
 
Rarely is M-OD applied to redesign the existing production 
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In this case, in order to choose correctly, the payback time 
of the investment in the redesign should be estimated in 
advance. 
 
The company determined that the choice to redesign was 
convenient, by comparing the payback time with the useful 
life of the new bottling machine. 
 
The technical solution chosen by the designers who were 
assigned to the redesign, consists in a physical separation 
of most of the transmission parts and all the parts involved 
in frequent maintenance activities from the clean room 
where the bottles are filled [22]. 
 
For this purpose, technical compartments with separate 
access were created, totally isolated from the clean room. 
This solution provides a substantial decrease in 
sterilization operations performed after maintenance. 
 
This choice is totally consistent with the current approach 
of maintenance-oriented design for industrial production 
in clean rooms. 
 
5. Maintenance-oriented design: results 
 
Once the new plant started production, observation was 
carried out for a period of 150 days, in order to collect new 
data on downtime. The results obtained are summarized in 
table 3. 
 
Types of downtime  Time (min)
Micro-stops 602 
Weekly cleaning 3,420 
Cleaning for batch change 360 
Macro-stops (with sterilization) 1,007 
Macro-stops (without sterilization) 2,280 
Tot 7,669
Table 3. Rates of downtime of the bottling device after redesign 
 
The redesign of the bottling line reduced the total hours of 
non-operation. Thanks to an investment of approximately 
€ 285,000.00, a reduction of almost 20% was achieved, as 
shown in figure 2. This improvement is due to a substantial 
reduction of macro-stops, which require sterilization 
following maintenance. Many of the maintenance activities 
are now possible without personnel coming into contact 
with the clean room. The increase of the number of hours 
of macro-stops without sterilization is a direct result of the 
redesign. For the other causes of downtime, however, the 
values were almost identical. 
 
Over a working time of 135,000 minutes, the new value of 
plant availability is A (t) = 94.32%. 
 
 
Figure 2. Downtime comparison before and after the 
maintenance-oriented design (M-OD) application 
 
The total unavailability due to the overall macro-stops is U 
(t) = 2.43%, equivalent to 3,287 minutes in the observation 
period. This period of unavailability involves a loss of 
theoretical production equal to 131,480 units over 135,000 
minutes of working, corresponding to approximately 




Comparing the data from before and after the changes, it is 
possible to evaluate the results in terms of the performance 
improvement of the system [23-24], due to the 
maintenance-oriented redesign of the bottling system. 
 
An analysis of the results is summarized in table 4. 
 
The benefits in terms of performance obtained are 
significant and it is clear that the increase of system 
availability is totally due to the time saved by the reduction 
of sterilization operations. 
 
Considering a production efficiency η = 0.92, an increase 
in the theoretical production equal to 119,780 units 
corresponds to a real increase of about 110,200 units. 
 
By knowing the value of the gross margin contribution 
per unit, equal to 0.47 €/u, it is possible to convert the 
increase in production obtained in a GMC increase per 
year of approximately € 51,800.00, which allows a 
payback time for the investment in redesign 
(approximately 300,000.00 €) to be achieved in less than 
six years [25]. 
 
Thanks to the case study presented it was possible to 
assess the impact on the production of maintenance-
oriented design solutions, both from a technical and 
economic point of view. 
 
By extending the same analysis to additional cases, it 
would be possible to obtain a range of specific reference 
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Loss of production  
(135,000 minutes) 
200,320 131,480 
Loss of production per year 
(234,900 minutes) 
348,550 228,770 
Table 4. Comparison between the characteristic parameters of 
the system, before and after the application of M-OD  
 
The case study also shows how the M-OD may have a 
profitable application even in the case of a redesign of 
existing systems. 
 
In this context it is appropriate to relate the payback time 
with the useful life of the new equipment and also with 
the residual time of those needing to be replaced. 
 
The redesign is in fact much more convenient as the 
equipment to be replaced is close to the period of failure 
due to wear and tear. 
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